[go: up one dir, main page]

BR9703385A - Análogs fluorados da vitamina d3 - Google Patents

Análogs fluorados da vitamina d3

Info

Publication number
BR9703385A
BR9703385A BR9703385A BR9703385A BR9703385A BR 9703385 A BR9703385 A BR 9703385A BR 9703385 A BR9703385 A BR 9703385A BR 9703385 A BR9703385 A BR 9703385A BR 9703385 A BR9703385 A BR 9703385A
Authority
BR
Brazil
Prior art keywords
analogs
fluorinated vitamin
fluorinated
vitamin
Prior art date
Application number
BR9703385A
Other languages
English (en)
Inventor
Percy Sarwood Manchand
Milan Radoje Uskokovic
John Joseph Nestor Jr
Brian Henry Vickery
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9703385A publication Critical patent/BR9703385A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9703385A 1996-05-23 1997-05-23 Análogs fluorados da vitamina d3 BR9703385A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (1)

Publication Number Publication Date
BR9703385A true BR9703385A (pt) 1998-09-15

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703385A BR9703385A (pt) 1996-05-23 1997-05-23 Análogs fluorados da vitamina d3

Country Status (26)

Country Link
EP (1) EP0808832B1 (pt)
JP (1) JP2859248B2 (pt)
KR (1) KR100253961B1 (pt)
CN (1) CN100402497C (pt)
AR (1) AR007776A1 (pt)
AT (1) ATE238278T1 (pt)
AU (1) AU733970B2 (pt)
BR (1) BR9703385A (pt)
CA (1) CA2205315C (pt)
CO (1) CO4940503A1 (pt)
CZ (1) CZ157797A3 (pt)
DE (1) DE69721123T2 (pt)
DK (1) DK0808832T3 (pt)
ES (1) ES2195049T3 (pt)
HR (1) HRP970272A2 (pt)
HU (1) HUP9700928A3 (pt)
IL (1) IL120844A0 (pt)
MA (1) MA24250A1 (pt)
NO (1) NO972278L (pt)
NZ (1) NZ314840A (pt)
PE (1) PE66798A1 (pt)
PL (1) PL320130A1 (pt)
PT (1) PT808832E (pt)
SG (1) SG70010A1 (pt)
TR (1) TR199700416A2 (pt)
YU (1) YU20097A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
PT103177A (pt) 2003-09-24 2005-03-31 Bioxell Spa 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2601914A1 (en) * 2005-03-23 2006-09-28 Bioxell S.P.A. 20-alkyl, gemini vitamin d3 compounds and methods of use thereof
CN104829510B (zh) 2010-10-25 2016-05-04 帝人制药株式会社 23-炔-维生素d3衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
AU7295696A (en) * 1995-10-27 1997-05-22 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
EP0808832B1 (en) 2003-04-23
HRP970272A2 (en) 1998-04-30
JP2859248B2 (ja) 1999-02-17
KR100253961B1 (ko) 2000-04-15
SG70010A1 (en) 2000-01-25
MX9703775A (es) 1998-06-30
CN100402497C (zh) 2008-07-16
PE66798A1 (es) 1998-10-22
CO4940503A1 (es) 2000-07-24
TR199700416A2 (xx) 1997-12-21
EP0808832A2 (en) 1997-11-26
CZ157797A3 (en) 1997-12-17
NZ314840A (en) 1998-11-25
NO972278L (no) 1997-11-24
AR007776A1 (es) 1999-11-24
ES2195049T3 (es) 2003-12-01
IL120844A0 (en) 1997-09-30
HUP9700928A3 (en) 1999-07-28
PL320130A1 (en) 1997-11-24
EP0808832A3 (en) 1999-02-03
HU9700928D0 (en) 1997-07-28
CN1172801A (zh) 1998-02-11
MA24250A1 (fr) 1998-04-01
ATE238278T1 (de) 2003-05-15
DE69721123D1 (de) 2003-05-28
DK0808832T3 (da) 2003-08-11
NO972278D0 (no) 1997-05-20
AU2357697A (en) 1997-11-27
PT808832E (pt) 2003-07-31
HUP9700928A2 (hu) 1998-01-28
JPH1045714A (ja) 1998-02-17
CA2205315A1 (en) 1997-11-23
DE69721123T2 (de) 2004-01-08
KR970074764A (ko) 1997-12-10
AU733970B2 (en) 2001-05-31
CA2205315C (en) 2006-10-24
YU20097A (sh) 1999-09-27

Similar Documents

Publication Publication Date Title
PT808833E (pt) Analogos da vitamina d3
PT1124779E (pt) Analogos da vitamina d
EE03832B1 (et) Heptapeptiidanaloogid
FI960303L (fi) D-vitamiinianalogeja
BR9703373A (pt) Análogos de vitamina d3 fluorados
DK0915819T3 (da) Illudinanaloger anvendt som antitumormiddel
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
DE69702261D1 (de) Sprachkodierung
FI951134L (fi) Fluorattu D3-vitamiinijohdannainen
BR9703385A (pt) Análogs fluorados da vitamina d3
ZA974332B (en) Fluorinated vitamin D3 analogs.
KR980001810U (ko) 자동으로 절첩되는 자동차의 발받침대
ITMI941736A0 (it) Attrezzatura da alpinismo
SG24096A1 (en) Fluorinated vitamin D3 derivative
FR2736803B1 (fr) Composition vitaminee stabilisee
SE9704790D0 (sv) Vitaminkomposition
BR7401340U (pt) Corrimão iluminado
KR970049050U (ko) 앰블런스의 물받이부재
FI960675A0 (fi) Kortslutningsskydd foer en som belastningskoppling fungerande FET-transistor
FI961508A0 (fi) Ledningskanal som ocksao fungerar som foensterbraede
FI963725A0 (fi) Bastuugn som vaermar vatten

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ARTS. 8O, 13, 24 E 25 DA LPI 9279/96